President Donald Trump speaks speaks on the latest developments of the coronavirus outbreak, while flanked by White House coronavirus response coordinator Debbie Birx (L), and U.S. Surgeon General Jerome Adams (R), in the James Brady Press Briefing Room at the White House March 19, 2020. (Photo by Chip Somodevilla/Getty Images)
President Donald Trump in a press conference on Thursday said the Food and Drug Administration is fast-tracking efforts to approve an antiviral therapy, best known for treating malaria, for use in coronavirus cases.
The drug, hydroxychloroquine, was developed more than a half-century ago and is approved for treating malaria, arthritis, and other ailments. Reports out of China and Italy suggest the drug may help, but there is no hard data yet.
"We're going to be able to make that drug available almost immediately," Trump said.
The FDA is working to conduct a "large, pragmatic clinical trial" quickly to confirm the drug's benefit to coronavirus patients, said Commissioner Dr. Stephen Hahn.
He also tempered the president's optimism about the still-untested solution.
"What's also important is not to provide false hope," he said. "We may have the right drug, but it might not be in the appropriate dosage form right now, and it might do more harm than good."
New antiviral therapies face a shorter and less arduous approval process than vaccines, several of which are under development with 12 to 18-month timelines.
"The therapies are something we could move on much faster potentially," Trump said.
He claimed the administration "slashed red tape" to develop new vaccines and therapies.
The president also held out on confirming whether he would invoke the Defense Production Act, which he signed on Wednesday, to mandate the production of needed medical supplies such as N95 respirators and surgical masks.
"If we find that we need something, then we will do that," he said.
Trump repeated that he was open to the federal government buying equity stakes in the airline, cruise, hospitality, and other industries hurt by the outbreak.
The press conference opened with more controversial language placing the blame squarely on China for the outbreak, despite concerns voiced about potentially exacerbating a backlash against Asian Americans.
"We continue our relentless effort to defeat the Chinese virus," Trump said.
Russian forces escalated their attacks on populated urban areas Tuesday, bombarding the central square in Ukraine’s second-largest city and Kyiv’s main TV tower.
A bipartisan group of 43 representatives joined forces in a letter to President Joe Biden to remind the executive branch that it must seek the approval of Congress before authorizing a war — whether or not its in Ukraine as Russia continues its invasion. Rep. Peter DeFazio (D-Ore. 4th District) led the effort and joined Cheddar News Wrap to explain. "It's time for Congress to get back the authority, which is vested to us in the constitution, not in the executive branch," he said. "The president. once we're at war, we speak with one voice with the commander in chief. But before that, it's up to the American people and Congress whether or not we're going to become engaged in a war."
Chris Konstantinos, Chief Investment Strategist at RiverFront Investment Group, explains why he remains encouraged about the S&P and the state of the market despite the major indexes closing mostly lower on Monday.
President Joe Biden will be delivering his first State of the Union address on Tuesday night, and with so many issues from Ukraine to inflation, everyone will be focused on what he might say. Rep. Nicole Malliotakis (R-N.Y. 11th District) joined Cheddar News to discuss what she thinks the president should address. "I think what he hasn't done yet is go after the gas, the oil, the minerals, the mining industries, that is incredibly important," she said. "There's still some banks there that are not sanctioned. He needs to go after all the banks, but I also think that providing the equipment that Ukraine needs to continue to protect its capital and its country are incredibly important."
As Russia’s attack on Ukraine continues, one of its few big allies remaining appears to be China. Gordon Chang, Asian affairs expert and author of "The Coming Collapse of China," joined Cheddar News to discuss what might be behind China's support for Putin's current strategy. “I think China is looking at what Putin did yesterday, which is to raise his nuclear forces on a higher alert level,” Chang stated, “If they see that Putin gets away with his nuclear threats, which he's been making over the last three or four days, then I'm sure that Beijing is going to ramp up its threats as well, and it could ramp them up against any number of different countries with which it perceives it has a problem with"
Joel Rubin, president of the Washington Strategy Group and former Deputy Assistant Secretary of State, joins Cheddar News to discuss the Russia-Ukraine tensions and the new sanctions President Biden placed on Russia.
